Diseases of the Kidney and the Urinary System

Total Page:16

File Type:pdf, Size:1020Kb

Diseases of the Kidney and the Urinary System Chapter 36 Diseases of the Kidney and the Urinary System John Dirks, Giuseppe Remuzzi, Susan Horton, Arrigo Schieppati, and S. Adibul Hasan Rizvi CAUSES AND CHARACTERISTICS OF THE BURDEN worldwide are on RRT, 80 percent of whom live in Japan, OF DISEASES Europe, and North America (Weening 2004). The percentage of patients on regular dialysis varies across Estimates of the global burden of disease indicate that diseases countries as a consequence of the capacity of health care systems of the kidney and urinary tract account for approximately to provide treatment. Europe is an example. Whereas in the 830,000 deaths and 18,467,000 disability-adjusted life years 15countriesof theEuropeanUnion(before2004)theprevalence annually, ranking them 12th among causes of death (1.4 per- rate of RRT was approximately 650 patients per 1 million people, cent of all deaths) and 17th among causes of disability (1.0 per- in Central and Eastern Europe it was only 160 patients per 1 mil- cent of all disability-adjusted life years). This ranking is similar lion people, reflecting differences in gross national product. across World Bank regions (table 36.1). Much less is known about the prevalence of earlier stages of Recent research suggests that the data shown in table 36.1 CKD, when symptoms may be mild, ignored, or undiagnosed. underestimate the global prevalence of kidney disease. Chronic A lack of standardization of the stages of CKD has hampered kidney disease (CKD) patients often suffer from cardiovascular assessments of the burden of CKD. In an attempt to carry out or cerebrovascular disease, and their deaths may be attributed such an assessment, the National Center for Health Statistics of to either complication (Hostetter 2004). Altered kidney func- the Centers for Disease Control and Prevention in the United tion is often found in patients with hypertensive and ischemic States conducted a survey from 1988 to 1994. The center ana- heart disease, both of which are associated with increased car- lyzed a sample of 15,625 noninstitutionalized individuals diovascular morbidity and mortality. Approximately 30 per- age 20 and older and defined five stages of renal dysfunction cent of patients with diabetes have diabetic nephropathy, with according to estimates of renal function and urine albumin higher rates found in some ethnic groups (King, Aubert, and level. Coresh and others (2003) found that the estimated preva- Herman 1998). Table 36.2 shows that both genders are similarly lence of CKD in the United States is 11 percent of the adult affected by kidney disease (Coresh and others 2003). population, or 19.8 million people. Nationally representative Generally, renal diseases progress to a final stage as end- data on U.S. adults older than 20 show that 6.3 percent, or stage renal disease (ESRD) and function is substituted by renal 11 million people, have stage 1 CKD, or kidney damage (pro- replacement therapy (RRT), hemodialysis, peritoneal dialysis, teinuria) with normal kidney function (Glomerular Function or transplantation. National and international registries of Rate (GFR) at least 90 milliliters per minute in 1.73 per meter patients on RRT are useful for providing information on the squared) or stage 2 CKD, that is, mildly reduced kidney func- prevalence of renal diseases in a given country. Data combined tion (60 to 89 ml/min/1.73 m2). Furthermore, 4.3 percent, from different sources show that more than 1.5 million people or 7.6 million people, exhibit stage 3 CKD, or moderately 695 Table 36.1 Contribution of Diseases of the Kidney and Urinary System to the Global Burden of Disease by Gender and Region (thousands) Disability-adjusted Years lived Years of Gender and region Population Deaths life years with disability life lost Females 3,056,384 397 8,008 2,546 5,450 Males 3,093,849 433 10,459 4,493 5,960 World 6,150,233 830 18,647 7,039 11,415 East Asia and the Pacific 1,850,775 233 5,400 1,858 3,530 Europe and Central Asia 447,180 53 1,417 623 793 Latin America and the Caribbean 526,138 70 1,667 779 888 Middle East and North Africa 309,762 57 1,283 460 823 South Asia 1,387,873 156 3,991 1,373 2,619 Sub-Saharan Africa 667,663 107 2,623 1,046 1,576 Source: Mathers and others 2006. Table 36.2 Global Deaths Caused by Diseases of the Genitourinary System by Gender and Age Age (years) Gender Birth–4 5–14 15–29 30–44 45–59 60–69 70–79 80+ Male deaths Number (thousands) 11 7 24 43 80 86 110 88 Percent 3 2 5 10 18 19 24 20 Female deaths Number (thousands) 10 6 21 29 61 66 85 98 Percent 3 2 5 8 16 18 23 24 Source: WHO 2002. reduced kidney function (30 to 59 ml/min/1.73 m2), and 0.2 technology. The characterization of inherited kidney diseases percent, or 400,000, have stage 4 CKD, or severely reduced kid- has improved, and novel mutations leading to selective renal ney function (15 to 29 ml/min/1.73 m2) (Coresh and others defects have been described. Inherited kidney diseases are rare, 2003; Coresh, Astor, and Sarnak 2004; National Kidney with the exception of autosomal dominant polycystic kidney Foundation 2002). A sizable proportion (360,000) of these disease, the fourth most common cause of ESRD in developed patients eventually progress toward ESRD (stage 5, or less than countries. This disease has a prevalence of 1 in 1,000 people 15 ml/min/1.73 m2) and require RRT. Early detection of CKD and affects approximately 10 million people worldwide is, therefore, important to retard or arrest the loss of renal func- (Grantham 1997). Autosomal recessive polycystic kidney dis- tion. Late detection of CKD is a lost opportunity for making ease is less frequent, with an incidence of 1 in 40,000, but is an lifestyle changes and initiating therapeutic measures. important hereditary disease of childhood (Guay-Woodford, Jafri, and Bernstein 2000). Many other inherited diseases can lead to ESRD, but together they account for only a small per- CAUSES OF DISEASES OF THE KIDNEY centage of all people with ESRD. AND URINARY SYSTEM Kidney disease leading to ESRD has many causes. The preva- lence varies by country, region, ethnicity, gender, and age. Glomerulonephritis Glomerulonephritides are a group of kidney diseases that affect the glomeruli. They fall into two major categories: glomeru- Genetic Diseases lonephritis refers to an inflammation of the glomeruli and can Knowledge of inherited kidney disease has changed radically be primary or secondary, and glomerulosclerosis refers to scar- with advances in molecular biology and gene-sequencing ring of the glomeruli. Even though glomerulonephritis and 696 | Disease Control Priorities in Developing Countries | John Dirks, Giuseppe Remuzzi, Susan Horton, and others glomerulosclerosis have different causes, both can lead to 300 million are at risk. The disease causes lesions in the bladder ESRD. Glomerulonephritis ranks second after diabetes as the and predisposes those with the condition to secondary infec- foremost cause of ESRD in Europe. (Stengel and others 2003) tions, bladder cancers, and chronic pyelonephritis. and is the second leading cause of ESRD in the United States, Some 15 to 20 million people have tuberculosis (TB) world- according to the United States Renal Data System (http://www. wide, of whom 8 million to 10 million are infectious. ifrr.net/). Approximately 20 to 35 percent of patients requiring Genitourinary TB is a common form of extrapulmonary TB RRT have a glomerular disease. and is always secondary to the primary lesion, which usually Glomerular diseases are more prevalent and severe in tropi- occurs in the lung (Pasternak and Rubin 1997). Lesions cal regions and low-income countries (Seedat 2003).A common referred to as ulcero-cavernous or miliary affect the kidneys. If mode of presentation is the nephrotic syndrome, with the age of left untreated, such lesions may progress to kidney destruction. onset at five to eight years. Estimates indicate that 2 to 3 percent Early recognition of and effective therapy for TB substantially of medical admissions in tropical countries are caused by renal- decrease the consequences in relation to kidney function. related complaints, most resulting from glomerulonephritis. In the industrial countries, kidney stones are a common A number of kidney diseases that result from infectious dis- problem (Morton, Iliescu, and Wilson 2002), affecting 1 person eases, such as malaria, schistosomiasis, leprosy, filariasis, and in 1,000 annually, and the incidence is increasing in tropical hepatitis B virus, are exclusive to the tropics. HIV/AIDS can be developing countries (Robertson 2003). Factors such as age, complicated by several forms of kidney disease; however, sex, and ethnic and geographic distribution determine preva- patient data are sparse (Seedat 2003). lence. The peak age of onset is in the third decade, and preva- Acute poststreptococcal nephritis following a throat or skin lence increases with age until 70. infection caused by Group A streptococcus has almost disap- Although largely idiopathic, the following risk factors are peared in high-income countries because of improved hygiene associated with stone disease: low urine volume, hyperurico- and treatment but remains an important glomerular disease in suria, hyperoxaluria, hypomagnesuria, and hypocitraturia. India and Africa, where epidemics have been reported (Seedat Diarrhea, malabsorption, low protein, low calcium, increased 2003). consumption of oxalate-rich foods, and low fluid intake may The eradication of endemic infections, along with improve- play a role in the genesis of stone disease. In developing coun- ments in socioeconomic status, education, sanitation, and tries, 30 percent of all pediatric urolithiasis cases occur as blad- access to treatment, is a crucial step toward decreasing the inci- der stones in children.
Recommended publications
  • Acute Kidney Injury: Challenges and Opportunities
    Acute kidney injury: Challenges and opportunities Abstract: Community-acquired acute kidney injury (CA-AKI) can be a devastating diagnosis for any patient and can increase mortality during hospitalization. There can be long-term consequences for those who survive the initial insult. This article discusses CA-AKI and its implications for APRNs. By Nhan L.A. Dinh, MSN, CNP, AGACNP-BC, CCRN cute kidney injury (AKI) is a heterogeneous risk of CKD, but if clinicians do not recognize the kidney disorder that increases in-hospital diagnosis, they cannot follow up or intervene. An AKI A morbidity and mortality. In 2016 data, the diagnosis also increases the chance of another AKI incidence of AKI was 20% for Medicare patients with episode, with a 30% risk of a recurrent AKI episode both chronic kidney disease (CKD) and diabetes.1 Us- within 1 year.1 ing Veterans Affairs (VA) 2016 data, AKI occurred in Mortality is increased with an AKI episode. Medi- more than 25% of hospitalized veterans over age 22, care data from 2016 shows an in-hospital mortality of but less than 50% of those with lab-documented AKI 8.2% but this increases to over 13% when includ- were coded as such.1 The chief concern here is a missed ing patients who were discharged to hospice.1 The in- opportunity for intervention. AKI increases long-term hospital mortality for patients without AKI was only Keywords: acute kidney injury (AKI), Acute Kidney Injury Network (AKIN), chronic kidney disease (CKD), community-acquired acute kidney injury (CA-AKI), hospital-acquired acute kidney injury (HA-AKI), Kidney Disease Improving Global Outcomes (KDIGO), SvetaZi / Shutterstock Nephrotoxic Injury Negated by Just-in-time Action (NINJA), sick day rules 48 The Nurse Practitioner • Vol.
    [Show full text]
  • Hypertensive Kidney Disease Hypertensive Kidney
    JAMA PATIENT PAGE The Journal of the American Medical Association KIDNEY DISEASE Hypertensive Kidney Disease ypertension (high blood pressure) causes problems for many organs in the body, including the kidneys. Kidney problems Hcaused by high blood pressure (hypertensive kidney disease) occur often in persons who have undetected, untreated, or poorly controlled hypertension. Kidney problems are also called renal dysfunction or renal failure. Certain groups of people, including African Americans and Native Americans, are more at risk for having hypertensive kidney disease. High blood pressure is the second leading cause of kidney failure, surpassed only by diabetes. African Americans are 6 times more likely than whites to have chronic renal failure related to high blood pressure. The November 20, 2002, issue of JAMA includes an article about high blood pressure and its effect on the kidneys. WHY IS HIGH BLOOD PRESSURE DANGEROUS? FOR MORE INFORMATION High blood pressure makes the heart work harder and can also damage the small blood • American Heart Association vessels in the body. These vessels are in all organs of the body, including the kidneys, the 800/242-8721 heart, and the brain. Damage to the arteries (blood vessels that carry blood to organs) www.americanheart.org results in insufficient blood flow to those organs and organ damage. In the kidney, this • National Institute of Diabetes & organ damage is called nephrosclerosis. The kidneys lose their ability to filter blood, Digestive & Kidney Diseases allowing buildup of substances that can be toxic to the body. Eventually the kidneys fail, www.niddk.nih.gov/health/kidney and dialysis (filtration of blood by a special machine) or a kidney transplant becomes /pubs/highblood/highblood.htm necessary to preserve the person’s life.
    [Show full text]
  • Uremic Toxins Affect Erythropoiesis During the Course of Chronic
    cells Review Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review Eya Hamza 1, Laurent Metzinger 1,* and Valérie Metzinger-Le Meuth 1,2 1 HEMATIM UR 4666, C.U.R.S, Université de Picardie Jules Verne, CEDEX 1, 80025 Amiens, France; [email protected] (E.H.); [email protected] (V.M.-L.M.) 2 INSERM UMRS 1148, Laboratory for Vascular Translational Science (LVTS), UFR SMBH, Université Sorbonne Paris Nord, CEDEX, 93017 Bobigny, France * Correspondence: [email protected]; Tel.: +33-2282-5356 Received: 17 July 2020; Accepted: 4 September 2020; Published: 6 September 2020 Abstract: Chronic kidney disease (CKD) is a global health problem characterized by progressive kidney failure due to uremic toxicity and the complications that arise from it. Anemia consecutive to CKD is one of its most common complications affecting nearly all patients with end-stage renal disease. Anemia is a potential cause of cardiovascular disease, faster deterioration of renal failure and mortality. Erythropoietin (produced by the kidney) and iron (provided from recycled senescent red cells) deficiencies are the main reasons that contribute to CKD-associated anemia. Indeed, accumulation of uremic toxins in blood impairs erythropoietin synthesis, compromising the growth and differentiation of red blood cells in the bone marrow, leading to a subsequent impairment of erythropoiesis. In this review, we mainly focus on the most representative uremic toxins and their effects on the molecular mechanisms underlying anemia of CKD that have been studied so far. Understanding molecular mechanisms leading to anemia due to uremic toxins could lead to the development of new treatments that will specifically target the pathophysiologic processes of anemia consecutive to CKD, such as the newly marketed erythropoiesis-stimulating agents.
    [Show full text]
  • Glomerulonephritis Management in General Practice
    Renal disease • THEME Glomerulonephritis Management in general practice Nicole M Isbel MBBS, FRACP, is Consultant Nephrologist, Princess Alexandra lomerular disease remains an important cause Hospital, Brisbane, BACKGROUND Glomerulonephritis (GN) is an G and Senior Lecturer in important cause of both acute and chronic kidney of renal impairment (and is the commonest cause Medicine, University disease, however the diagnosis can be difficult of end stage kidney disease [ESKD] in Australia).1 of Queensland. nikky_ due to the variability of presenting features. Early diagnosis is essential as intervention can make [email protected] a significant impact on improving patient outcomes. OBJECTIVE This article aims to develop However, presentation can be variable – from indolent a structured approach to the investigation of patients with markers of kidney disease, and and asymptomatic to explosive with rapid loss of kidney promote the recognition of patients who need function. Pathology may be localised to the kidney or further assessment. Consideration is given to the part of a systemic illness. Therefore diagnosis involves importance of general measures required in the a systematic approach using a combination of clinical care of patients with GN. features, directed laboratory and radiological testing, DISCUSSION Glomerulonephritis is not an and in many (but not all) cases, a kidney biopsy to everyday presentation, however recognition establish the histological diagnosis. Management of and appropriate management is important to glomerulonephritis (GN) involves specific therapies prevent loss of kidney function. Disease specific directed at the underlying, often immunological cause treatment of GN may require specialist care, of the disease and more general strategies aimed at however much of the management involves delaying progression of kidney impairment.
    [Show full text]
  • The Links Between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling—A Systematic Review
    toxins Article The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling—A Systematic Review Alicja Rydzewska-Rosołowska 1,* , Natalia Sroka 1, Katarzyna Kakareko 1, Mariusz Rosołowski 2 , Edyta Zbroch 1 and Tomasz Hryszko 1 1 2nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Białystok, 15-276 Białystok, Poland; [email protected] (N.S.); [email protected] (K.K.); [email protected] (E.Z.); [email protected] (T.H.) 2 Department of Gastroenterology and Internal Medicine, Medical University of Białystok, 15-276 Białystok, Poland; [email protected] * Correspondence: [email protected] Received: 30 October 2020; Accepted: 9 December 2020; Published: 11 December 2020 Abstract: The last years have brought an abundance of data on the existence of a gut-kidney axis and the importance of microbiome in kidney injury. Data on kidney-gut crosstalk suggest the possibility that microbiota alter renal inflammation; we therefore aimed to answer questions about the role of microbiome and gut-derived toxins in acute kidney injury. PubMed and Cochrane Library were searched from inception to October 10, 2020 for relevant studies with an additional search performed on ClinicalTrials.gov. We identified 33 eligible articles and one ongoing trial (21 original studies and 12 reviews/commentaries), which were included in this systematic review. Experimental studies prove the existence of a kidney-gut axis, focusing on the role of gut-derived uremic toxins and providing concepts that modification of the microbiota composition may result in better AKI outcomes. Small interventional studies in animal models and in humans show promising results, therefore, microbiome-targeted therapy for AKI treatment might be a promising possibility.
    [Show full text]
  • Pyelonephritis (Kidney Infection)
    Pyelonephritis (Kidney Infection) Cathy E. Langston, DVM, DACVIM (Small Animal) BASIC INFORMATION urine collected from the bladder to be negative despite infection in the Description kidney. Abdominal x-rays and an ultrasound may be recommended. Bacterial infection of the kidney is termed pyelonephritis . Infection Although culture of a piece of kidney tissue obtained by biopsy may occur within kidney tissue or in the renal pelvis, the area of increases the chance of finding the infection, the invasiveness of the kidney where urine collects before being transported to the the procedure makes it too risky for general use (the biopsy would bladder. need to be taken from deeper within the kidney than the average Causes kidney biopsy). Contrast x-ray studies, such as an excretory uro- In most cases, a urinary tract infection starts in the bladder and gram (intravenous pyelogram), are sometimes helpful. An excre- the bacteria travel upstream to the kidney. Anything that decreases tory urogram involves taking a series of x-rays after a dye (that the free flow of urine, such as obstruction of the urethra (tube shows up white on x-rays) is given intravenously. Other tests may that carries urine from the bladder to the outside), bladder, ureter be recommended to rule out diseases that cause similar clinical (tube that carries urine from the kidney to the bladder), or kid- signs and other causes of kidney disease. ney, increases the risk that the infection will spread to the kid- ney. The presence of stones and growths in the bladder and kidney TREATMENT AND FOLLOW-UP also increases the risk.
    [Show full text]
  • Full Text (PDF)
    www.jasn.org EDITORIALS 5. Grimm PR, Coleman R, Delpire E, Welling PA: Constitutively active Cachexia with muscle wasting is prevalent and closely associated SPAK causes hyperkalemia by activating NCC and remodeling distal with mortality and morbidity in patients with CKD.1 The patho- – tubules. JAmSocNephrol28: 2597 2606, 2017 physiology of muscle wasting in CKD is complex. Inadequate 6. Moriguchi T, Urushiyama S, Hisamoto N, Iemura S, Uchida S, Natsume T, Matsumoto K, Shibuya H: WNK1 regulates phosphorylation of cation- nutritional intake, physical inactivity from muscle weakness, sys- chloride-coupled cotransporters via the STE20-related kinases, SPAK temic inflammation and aberrant signaling of neuropeptides have and OSR1. J Biol Chem 280: 42685–42693, 2005 been implicated.2 To date, there is no effective therapy. Exercise 7. YangSS,MorimotoT,RaiT,ChigaM,SoharaE,OhnoM,UchidaK,LinSH, training has well documented health benefits, including mainte- Moriguchi T, Shibuya H, Kondo Y, SasakiS,UchidaS:Molecularpatho- nance of muscle mass as well as increased physical performance genesis of pseudohypoaldosteronism type II: Generation and analysis of a fi Wnk4(D561A/1) knockin mouse model. Cell Metab 5: 331–344, 2007 resulting from changes in muscle ber phenotype leading to in- 8. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson- creased mitochondrial biogenesis. The molecular signaling mech- Williams C, Ellison DH, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP: Wnk4 anism underlying adaptations to increased physical activity in controls blood pressure and potassium homeostasis via regulation of mass CKD-associated muscle wasting is not well understood. – and activity of the distal convoluted tubule.
    [Show full text]
  • Urinalysis and Kidney Disease: What You Need to Know
    URINALYSIS AND KIDNEY DISEASE What You Need To Know www.kidney.org About the Information in this Booklet Did you know that the National Kidney Foundation (NKF) offers guidelines and commentaries that help your healthcare provider make decisions about your medical treatment? The information in this booklet is based on those recommended guidelines. Stages of Kidney Disease There are five stages of kidney disease. They are shown in the table below. Your healthcare provider determines your stage of kidney disease based on the presence of kidney damage and your glomerular filtration rate (GFR), which is a measure of your kidney function. Your treatment is based on your stage of kidney disease. Speak to your healthcare provider if you have any questions about your stage of kidney disease or your treatment. STAGES OF KIDNEY DISEASE Glomerular Stage Description Filtration Rate (GFR)* Kidney damage (e.g., protein 1 90 or above in the urine) with normal GFR Kidney damage with mild 2 60 to 89 decrease in GFR 3 Moderate decrease in GFR 30 to 59 4 Severe reduction in GFR 15 to 29 5 Kidney failure Less than 15 *Your GFR number tells your healthcare provider how much kidney function you have. As chronic kidney disease progresses, your GFR number decreases. What is a urinalysis (also called a “urine test”)? A urinalysis is a simple test that looks at a small sample of your urine. It can help find conditions that may need treatment, including infections or kidney problems. It can also help find serious diseases in the early stages, like chronic kidney disease, diabetes, or liver disease.
    [Show full text]
  • High Blood Pressure and Chronic Kidney Disease: for People
    HIGH BLOOD PRESSURE AND CHRONIC KIDNEY DISEASE For People with CKD Stages 1–4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (NKF-KDOQI™) has guidelines and commentaries that help your doctor and healthcare team make important decisions about your medical treatment? The information in this booklet is based on the NKF- KDOQI recommended guidelines and commentaries. What is your stage of kidney disease? There are five stages of kidney disease. They are shown in the table below. Your doctor determines your stage of kidney disease based on the presence of kidney damage and your glomerular filtration rate (GFR), which is a measure of your level of kidney function. Your treatment is based on your stage of kidney disease. Speak to your doctor if you have any questions about your stage of kidney disease or your treatment. STAGES of KidNEY DISEASE AGES of KidNEY DISEASE STAGES OF KIDNEY DISEASE Stage Description Glomerular Filtration Rate (GFR)* Kidney damage (e.g., protein 1 90 or above in the urine) with normal GFR Kidney damage with mild 2 60 to 89 decrease in GFR 3 Moderate decrease in GFR 30 to 59 4 Severe reduction in GFR 15 to 29 5 Kidney failure Less than 15 *Your GFR number tells your doctor how much kidney function you have. As chronic kidney disease progresses, your GFR number decreases. 2 NATIONAL KIDNEY FOUNDATION TABLE of ConTEntS Did you know? ...............................4 What is chronic kidney disease? ................5 What is high blood pressure? ...................6 How are high blood pressure and kidney disease related? ..............................6 How do I know if my blood pressure is too high? ..................................7 How is blood pressure measured? How often should it be checked? ...............8 I have high blood pressure but am not sure if I have CKD.
    [Show full text]
  • Mineralocorticoid-Resistant Renal Hyperkalemia Without Salt Wasting
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Kidney International, Vol. 19 (1981), pp. 716—727 Mineralocorticoid-resistant renal hyperkalemia without sal wasting (type II pseudohypoaldosteronism): Role of increased renal chloride reabsorption MORRIS SCHAMBELAN, ANTHONY SEBASTIAN, and FLOYD C. RECTOR, JR. Medical Service and Clinical Study Center, San Francisco General Hospital Medical Center, and the Department of Medicine, Cardiovascular Research Institute, and the General Clinical Research Center, University of California, San Francisco, California Mineralocorticoid-resistant renal hyperkalemia without salt Hyperkaliemie rénale resistant aux minéralocorticoides sans wasting (type II pseudohypoaldosteronism): Role of increased perte de sel (pseudohypoaldostéronisme de type II): Role de l'aug- renal chloride reabsorption. A rare syndrome has been described mentation iie Ia reabsorption de chlore. Un syndrome rare a été in which mineralocorticoid-resistant hyperkalemia of renal origin décrit dans lequel une hyperkaliemie d'origine rénale resistant occurs in the absence of glomerular insufficiency and renal aux minéralocorticoides survient en l'absence de diminution du sodium wasting and in which hyperchioremic acidosis, hyperten- debit de filtration glomerulaire et de perte rénale de sodium et sion, and hyporeninemia coexist. The primary abnormality has dans lequel une acidose hyperchioremique, une hypertension et been postulated to be a defect of the potassium secretory une hyporéninémie coexistent. L'anomalie primaire qui a été mechanism of the distal nephron. The present studies were postulée est un deficit du mécanisme de secretion de potassium carried out to investigate the mechanism of impaired renal du nephron distal. Ce travail a etC entrepris pour étudier le potassium secretion in a patient with this syndrome.
    [Show full text]
  • What Is Lupus Nephritis
    What is lupus nephritis (LN)? Lupus nephritis (LN) is inflammation of the kidney that occurs as a common symptom of systemic lupus erythematosus (SLE), also known as lupus. Proteins in the immune system called antibodies damage important structures in the kidney. ⅱ Why are the kidneys important? To understand how lupus nephritis damages the kidney, it is important to understand how the kidneys work. The kidneys’ main function is to filter out excess waste and water from the blood through the urine. Kidneys also balance the salts and minerals circulating in the blood, help control blood pressure and make red blood cells. So, when the kidneys are damaged or fail, they can’t do their job as well. As a result, the kidneys are not able to filter out waste and water into the urine causing it to stay in the blood. What are the signs and symptoms of LN? Signs to ask the doctor about include blood in the urine or foamy urine which can mean that there is excess protein. Other signs to notice are swelling of legs, ankles, hands or tissue around the eyes as well as weight gain that can be caused by fluid the body isn’t getting rid of. ⅲ Symptoms of lupus nephritis also include high blood pressure, joint/muscle pain, high levels of waste (creatinine) in the blood, or impaired/failing kidney. ⅳ How common is LN? Lupus nephritis is the most common complication of lupus. Five out of 10 adults with lupus will have lupus nephritis, while eight out of 10 children with lupus will have kidney damage, which usually stems from lupus nephritis.
    [Show full text]
  • Urinary System Diseases and Disorders
    URINARY SYSTEM DISEASES AND DISORDERS BERRYHILL & CASHION HS1 2017-2018 - CYSTITIS INFLAMMATION OF THE BLADDER CAUSE=PATHOGENS ENTERING THE URINARY MEATUS CYSTITIS • MORE COMMON IN FEMALES DUE TO SHORT URETHRA • SYMPTOMS=FREQUENT URINATION, HEMATURIA, LOWER BACK PAIN, BLADDER SPASM, FEVER • TREATMENT=ANTIBIOTICS, INCREASE FLUID INTAKE GLOMERULONEPHRITIS • AKA NEPHRITIS • INFLAMMATION OF THE GLOMERULUS • CAN BE ACUTE OR CHRONIC ACUTE GLOMERULONEPHRITIS • USUALLY FOLLOWS A STREPTOCOCCAL INFECTION LIKE STREP THROAT, SCARLET FEVER, RHEUMATIC FEVER • SYMPTOMS=CHILLS, FEVER, FATIGUE, EDEMA, OLIGURIA, HEMATURIA, ALBUMINURIA ACUTE GLOMERULONEPHRITIS • TREATMENT=REST, SALT RESTRICTION, MAINTAIN FLUID & ELECTROLYTE BALANCE, ANTIPYRETICS, DIURETICS, ANTIBIOTICS • WITH TREATMENT, KIDNEY FUNCTION IS USUALLY RESTORED, & PROGNOSIS IS GOOD CHRONIC GLOMERULONEPHRITIS • REPEATED CASES OF ACUTE NEPHRITIS CAN CAUSE CHRONIC NEPHRITIS • PROGRESSIVE, CAUSES SCARRING & SCLEROSING OF GLOMERULI • EARLY SYMPTOMS=HEMATURIA, ALBUMINURIA, HTN • WITH DISEASE PROGRESSION MORE GLOMERULI ARE DESTROYED CHRONIC GLOMERULONEPHRITIS • LATER SYMPTOMS=EDEMA, FATIGUE, ANEMIA, HTN, ANOREXIA, WEIGHT LOSS, CHF, PYURIA, RENAL FAILURE, DEATH • TREATMENT=LOW NA DIET, ANTIHYPERTENSIVE MEDS, MAINTAIN FLUIDS & ELECTROLYTES, HEMODIALYSIS, KIDNEY TRANSPLANT WHEN BOTH KIDNEYS ARE SEVERELY DAMAGED PYELONEPHRITIS • INFLAMMATION OF THE KIDNEY & RENAL PELVIS • CAUSE=PYOGENIC (PUS-FORMING) BACTERIA • SYMPTOMS=CHILLS, FEVER, BACK PAIN, FATIGUE, DYSURIA, HEMATURIA, PYURIA • TREATMENT=ANTIBIOTICS,
    [Show full text]